60 related articles for article (PubMed ID: 21844951)
1. [Expression and regulation of androgen receptor in the androgen-independent conversion of prostate cancer cells].
Wang HF; Liu WJ; Jin J; Zhou LQ; Liang LL; Wang Y; Guo YL
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Aug; 43(4):490-5. PubMed ID: 21844951
[TBL] [Abstract][Full Text] [Related]
2. LEF1 in androgen-independent prostate cancer: regulation of androgen receptor expression, prostate cancer growth, and invasion.
Li Y; Wang L; Zhang M; Melamed J; Liu X; Reiter R; Wei J; Peng Y; Zou X; Pellicer A; Garabedian MJ; Ferrari A; Lee P
Cancer Res; 2009 Apr; 69(8):3332-8. PubMed ID: 19351848
[TBL] [Abstract][Full Text] [Related]
3. The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growth.
Jin RJ; Lho Y; Connelly L; Wang Y; Yu X; Saint Jean L; Case TC; Ellwood-Yen K; Sawyers CL; Bhowmick NA; Blackwell TS; Yull FE; Matusik RJ
Cancer Res; 2008 Aug; 68(16):6762-9. PubMed ID: 18701501
[TBL] [Abstract][Full Text] [Related]
4. Chimeric molecules facilitate the degradation of androgen receptors and repress the growth of LNCaP cells.
Tang YQ; Han BM; Yao XQ; Hong Y; Wang Y; Zhao FJ; Yu SQ; Sun XW; Xia SJ
Asian J Androl; 2009 Jan; 11(1):119-26. PubMed ID: 19050678
[TBL] [Abstract][Full Text] [Related]
5. Secreted Frizzled-related protein-1 is a negative regulator of androgen receptor activity in prostate cancer.
Kawano Y; Diez S; Uysal-Onganer P; Darrington RS; Waxman J; Kypta RM
Br J Cancer; 2009 Apr; 100(7):1165-74. PubMed ID: 19277043
[TBL] [Abstract][Full Text] [Related]
6. Proteasome inhibitor PS-341 down-regulates prostate-specific antigen (PSA) and induces growth arrest and apoptosis of androgen-dependent human prostate cancer LNCaP cells.
Ikezoe T; Yang Y; Saito T; Koeffler HP; Taguchi H
Cancer Sci; 2004 Mar; 95(3):271-5. PubMed ID: 15016328
[TBL] [Abstract][Full Text] [Related]
7. The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines.
Sun T; Wang Q; Balk S; Brown M; Lee GS; Kantoff P
Cancer Res; 2009 Apr; 69(8):3356-63. PubMed ID: 19351832
[TBL] [Abstract][Full Text] [Related]
8. The effect of encomir-93 mimic transfection on the expression of miR-93 and PSA and androgen receptor in prostate cancer LNcap cell line.
Mokhtari H; Ebrahimi A; Nejati M; Barartabar Z; Damchi M; Khonakdar-Tarsi A; Zahedi M
Horm Mol Biol Clin Investig; 2023 Sep; 44(3):237-241. PubMed ID: 36995990
[TBL] [Abstract][Full Text] [Related]
9. Improvement in predicting tumorigenic phenotype of androgen-insensitive human LNCaP prostatic cancer cell subline in recombination with rat urogenital sinus mesenchyme.
Kanai M; Ishii K; Kanda H; Ogura Y; Kise H; Arima K; Sugimura Y
Cancer Sci; 2008 Dec; 99(12):2435-43. PubMed ID: 19018772
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylases are required for androgen receptor function in hormone-sensitive and castrate-resistant prostate cancer.
Welsbie DS; Xu J; Chen Y; Borsu L; Scher HI; Rosen N; Sawyers CL
Cancer Res; 2009 Feb; 69(3):958-66. PubMed ID: 19176386
[TBL] [Abstract][Full Text] [Related]
11. Complex regulation of human androgen receptor expression by Wnt signaling in prostate cancer cells.
Yang X; Chen MW; Terry S; Vacherot F; Bemis DL; Capodice J; Kitajewski J; de la Taille A; Benson MC; Guo Y; Buttyan R
Oncogene; 2006 Jun; 25(24):3436-44. PubMed ID: 16474850
[TBL] [Abstract][Full Text] [Related]
12. Sarcosine induces increase in HER2/neu expression in androgen-dependent prostate cancer cells.
Dahl M; Bouchelouche P; Kramer-Marek G; Capala J; Nordling J; Bouchelouche K
Mol Biol Rep; 2011 Oct; 38(7):4237-43. PubMed ID: 21755295
[TBL] [Abstract][Full Text] [Related]
13. HOXB13 promotes androgen independent growth of LNCaP prostate cancer cells by the activation of E2F signaling.
Kim YR; Oh KJ; Park RY; Xuan NT; Kang TW; Kwon DD; Choi C; Kim MS; Nam KI; Ahn KY; Jung C
Mol Cancer; 2010 May; 9():124. PubMed ID: 20504375
[TBL] [Abstract][Full Text] [Related]
14. Calpain-mediated androgen receptor breakdown in apoptotic prostate cancer cells.
Yang H; Murthy S; Sarkar FH; Sheng S; Reddy GP; Dou QP
J Cell Physiol; 2008 Dec; 217(3):569-76. PubMed ID: 18726991
[TBL] [Abstract][Full Text] [Related]
15.
Kim SY; Park JE; Lee HJ; Sim DY; Ahn CH; Park SY; Shim BS; Kim B; Lee DY; Kim SH
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474045
[TBL] [Abstract][Full Text] [Related]
16. RNA editing of androgen receptor gene transcripts in prostate cancer cells.
Martinez HD; Jasavala RJ; Hinkson I; Fitzgerald LD; Trimmer JS; Kung HJ; Wright ME
J Biol Chem; 2008 Oct; 283(44):29938-49. PubMed ID: 18708348
[TBL] [Abstract][Full Text] [Related]
17. TET2 binds the androgen receptor and loss is associated with prostate cancer.
Nickerson ML; Das S; Im KM; Turan S; Berndt SI; Li H; Lou H; Brodie SA; Billaud JN; Zhang T; Bouk AJ; Butcher D; Wang Z; Sun L; Misner K; Tan W; Esnakula A; Esposito D; Huang WY; Hoover RN; Tucker MA; Keller JR; Boland J; Brown K; Anderson SK; Moore LE; Isaacs WB; Chanock SJ; Yeager M; Dean M; Andresson T
Oncogene; 2017 Apr; 36(15):2172-2183. PubMed ID: 27819678
[TBL] [Abstract][Full Text] [Related]
18. Synthetic inhibitors of CDKs induce different responses in androgen sensitive and androgen insensitive prostatic cancer cell lines.
Mad'arová J; Lukesová M; Hlobilková A; Strnad M; Vojtesek B; Lenobel R; Hajdúch M; Murray PG; Perera S; Kolár Z
Mol Pathol; 2002 Aug; 55(4):227-34. PubMed ID: 12147712
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol Sulfonation Enzyme, SULT2B1b, Modulates AR and Cell Growth Properties in Prostate Cancer.
Vickman RE; Crist SA; Kerian K; Eberlin L; Cooks RG; Burcham GN; Buhman KK; Hu CD; Mesecar AD; Cheng L; Ratliff TL
Mol Cancer Res; 2016 Sep; 14(9):776-86. PubMed ID: 27341831
[TBL] [Abstract][Full Text] [Related]
20. Prohibitin Links Cell Cycle, Motility and Invasion in Prostate Cancer Cells.
Koushyar S; Uysal-Onganer P; Jiang WG; Dart DA
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
